Hypoxic reactivation of Kaposi's sarcoma associated herpesvirus [PDF]
Cell InsightHypoxic reactivation of Kaposi's sarcoma-associated herpesvirus (KSHV) refers to the phenomenon under low oxygen where the virus goes from latent to lytic replication.
Rajnish Kumar Singh +2 more
doaj +5 more sources
Kaposi's sarcoma-associated herpesvirus at 27 [PDF]
Tumour Virus Research, 2021 Kaposi's sarcoma-associated herpesvirus (KSHV) was discovered 27 years ago and its link to several pathologies – Kaposi's sarcoma, primary effusion lymphoma, and the B cell variant of Multicentric Castleman disease – is now well established.
Marta Maria Gaglia
doaj +4 more sources
Kaposi’s Sarcoma-associated Herpesvirus
Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2016 Background: Kaposi’s sarcoma (KS) revealed by Moritz Kaposi first time in 1872. In the early 1980, the prevalence of SK began to increase dramatically.
Novia Indriyani Adisty +2 more
doaj +3 more sources
Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil [PDF]
Brazilian Journal of Medical and Biological Research, 2006 Kaposi's sarcoma (KS) became a critical health issue with the emergence of acquired immunodeficiency syndrome (AIDS) in the 1980s. Four clinical-epidemiological forms of KS have been described: classical KS, endemic KS, iatrogenic KS, and AIDS-associated
S. Ramos-da-Silva +3 more
doaj +8 more sources
Kaposi’s Sarcoma-associated herpesvirus microRNAs [PDF]
Frontiers in Microbiology, 2012 Kaposi’s Sarcoma-associated herpesvirus (KSHV) is a human pathogenic -herpesvirus strongly associated with the development of Kaposi’s Sarcoma and B cell proliferative disorders, including primary effusion lymphoma (PEL).
Eva eGottwein
doaj +3 more sources
Pathology of Kaposi's sarcoma-associated herpesvirus infection [PDF]
Frontiers in Microbiology, 2011 Kaposi’s sarcoma-associated herpesvirus (KSHV, human herpesvirus 8, HHV-8) is a human herpesvirus, classified as a gamma-herpesvirus. KSHV is detected in Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and some cases of multicentric Castleman’s ...
Hitomi eFukumoto +4 more
doaj +3 more sources
Kaposi's Sarcoma-Associated Herpesvirus [PDF]
Current Opinion in Infectious Diseases, 2015 To discuss the role of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication in viral-associated diseases and assess the progress on targeting KSHV lytic replication as a strategy to prevent KSHV-related malignancies.New inhibitors of viral lytic replication are being developed as well as novel modalities are being investigated to target ...
Graciela, Andrei, Robert, Snoeck
core +4 more sources
The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus [PDF]
Advances in Virology, 2010 Kaposi's sarcoma-associated herpesvirus (KSHV) is the aetiological agent of Kaposi's sarcoma (KS), the most frequently arising malignancy in individuals with untreated HIV/AIDS.
Rebecca C. Robey +2 more
doaj +2 more sources
Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus [PDF]
Viruses, 2014 This review summarizes the current knowledge pertaining to Kaposi sarcoma-associated herpesvirus (KSHV) epidemiology and transmission. Since the identification of KSHV twenty years ago, it is now known to be associated with Kaposi’s sarcoma (KS ...
Veenu Minhas, Charles Wood
doaj +3 more sources
Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen. [PDF]
ChemMedChemBerwanger A +10 more
europepmc +3 more sources